Influenza News and Research

Latest Influenza News and Research

Researchers identify genetic risk factors contributing to pneumonia susceptibility and severity

Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.

21 Jan 2021

Scientists identify a molecular mechanism that protects the fetus from maternal infection

Researchers at Duke and Mt. Sinai have identified a molecular mechanism that prevents a viral infection during a mother's pregnancy from harming her unborn baby.

21 Jan 2021

COVID-19 has transformed the world of vaccines

Researchers at GlaxoSmithKline (GSK) in Italy and Belgium say the coronavirus disease 2019 (COVID-19) pandemic is transforming the world of vaccinology by accelerating vaccine development and the availability of powerful technologies.

20 Jan 2021

Carbon-based nanomaterials as potential COVID-19 treatments

An international team of researchers says that carbon-based nanomaterials (CBNs) could represent promising new approaches to treating coronavirus disease 2019 (COVID-19) pneumonia that is complicated by a secondary bacterial, viral or fungal infection.

19 Jan 2021

Essential oils from Greek herbs may protect against COVID-19

Researchers in Greece have demonstrated the antiviral effects of Cretan aromatic plant oils on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for coronavirus disease 2019 (COVID-19).

18 Jan 2021

Near-universal adoption of masks along with public health measures could eliminate disease spread

Research published this month in the Proceedings of the National Academy of Sciences found that near-universal adoption of nonmedical masks in public, combined with complementary public health measures, could reduce spread to essentially zero.

18 Jan 2021

NK and T cell subsets show distinctive lung-homing receptor profiles in COVID-19 patients

A new study reveals in detail the changes that occur in peripheral blood natural killer (NK) and T cells in COVID-19.

18 Jan 2021

New SARS-CoV-2 variant emerges in the U.S.

Even as the rollout of vaccines all over the world brings a glimmer of hope that the current coronavirus disease 2019 (COVID-19) pandemic may end in the near future, new variants continue to emerge, some with the potential to escape vaccine-induced or therapeutic antibodies. Now, a new preprint research paper published on the bioRxiv server describes a new American variant that may have become the dominant strain in the USA.

18 Jan 2021

Research suggests St. John's Wort and Echinacea could protect against COVID-19

Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

17 Jan 2021

Image-based deep learning haplotype-guided study maps the global adaptation of SARS-CoV-2

A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.

15 Jan 2021

Can cloth masks protect healthcare professionals from SARS-CoV-2?

Given the global scarcity of surgical masks, a recent review study examines this issue - dealing with the potential use of cloth masks in healthcare scenarios.

15 Jan 2021

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

A new study reports the virucidal and fusion-inhibiting attributes of snake venom against the COVID-19 agent SARS-CoV-2.

14 Jan 2021

Influenza drug enisamium a potential COVID-19 treatment

Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Jan 2021

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Morderna has announced plans to develop a range of new mRNA-based vaccines against other viruses, including the influenza virus, human immunodeficiency virus (HIV), and the Nipah virus.

13 Jan 2021

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.

13 Jan 2021

Study summarizes effectiveness of cloth masks in protecting clinicians from COVID-19

A rapid, evidence-based review summarizes the effectiveness of cloth masks in protecting health care clinicians from respiratory viral infections, such as COVID-19. Nine studies were included in the review, and all but one were conducted prior to the COVID-19 pandemic.

13 Jan 2021

SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses

What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic -- circulating in the general population -- and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists.

13 Jan 2021

Influenza News and Research

Latest Influenza News and Research

Researchers identify genetic risk factors contributing to pneumonia susceptibility and severity

Scientists identify a molecular mechanism that protects the fetus from maternal infection

COVID-19 has transformed the world of vaccines

Carbon-based nanomaterials as potential COVID-19 treatments

Essential oils from Greek herbs may protect against COVID-19

Near-universal adoption of masks along with public health measures could eliminate disease spread

NK and T cell subsets show distinctive lung-homing receptor profiles in COVID-19 patients

New SARS-CoV-2 variant emerges in the U.S.

Research suggests St. John's Wort and Echinacea could protect against COVID-19

Image-based deep learning haplotype-guided study maps the global adaptation of SARS-CoV-2

Can cloth masks protect healthcare professionals from SARS-CoV-2?

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

Influenza drug enisamium a potential COVID-19 treatment

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

Study summarizes effectiveness of cloth masks in protecting clinicians from COVID-19

SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses

Biologists reveal unusual structure of coronavirus protein linked to immune evasion

Scientists identify sensor in human lungs that detects SARS-CoV-2

Poor gut health may adversely affect COVID-19 prognosis

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Influenza News and Research

Latest Influenza News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in